A high-resolution ultrasound-based portable device will help physicians calculate bone loss in space travelers, according to researchers at NASA’s National Space Biomedical Research Institute. While focused on space-related health issues, NSBRI findings may translate into help for earth-bound patients with similar conditions.
A high-resolution ultrasound-based portable device will help physicians calculate bone loss in space travelers, according to researchers at NASA's National Space Biomedical Research Institute. While focused on space-related health issues, NSBRI findings may translate into help for earth-bound patients with similar conditions.
Studies of cosmonauts and astronauts who completed lengthy missions aboard the space station Mir showed that humans can sustain an average 2% loss of bone mass every month. The lower extremities and hips generally bear the brunt of bone loss and become particularly susceptible to fracture upon return to earth.
The technology, called Scanning Confocal Acoustic Diagnostic System (SCAD), will monitor bone density and strength outside the earth's gravitational pull. It will help physicians on the ground determine the rate of bone loss and severity of injuries sustained in space, as well as appropriate recovery planning, said Dr. Yi-Xian Qin, an associate team leader of NSBRI's development group.
"We are currently in the beginning phases of development, but eventually this technology can aid diagnosis for a number of skeletal disorders," Qin said.
Compared with FDA-approved quantitative ultrasound (QUS) technology clinically available for diagnosing osteoporosis, SCAD provides an image-based assessment of bone strength in a region of interest. The device, created by researchers at the Stony Brook University's department of biomedical engineering in New York, can increase ultrasound's accuracy and reduce noise from soft tissue by providing a real-time mapping of the bone.
In addition to its uses inflight, researchers anticipate SCAD could help physicians in several clinical fields improve the early diagnosis of conditions like osteopenia and osteoporosis, which are difficult to diagnose during their initial stages.
The SCAD project complements several other NSBRI studies looking into other space health concerns, including sleep and psychosocial disorders, muscle waste, cardiovascular changes, balance and orientation problems, and radiation exposure.
For more information from the Diagnostic Imaging archives:
BMD testing hits its stride in community imaging
DXA products and QCT offer opportunities for radiologists
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Month, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.